Blood pressure and progression of brain atrophy the SMART-MR study

JAMA Neurology

Volumn 70, Issue 8, 2013, Pages 1046-1053

  Jochemsen, Hadassa M ^a,c   Muller, Majon ^a,d   Visseren, Frank L ^a   Scheltens, Philip ^c   Vincken, Koen L ^b   Mali, Willem P ^a   Van Der Graaf, Yolanda ^a   Geerlings, Mirjam I ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^c VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^d VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; BLOOD PRESSURE; BLOOD PRESSURE MEASUREMENT; BRAIN ATROPHY; BRAIN SIZE; DIASTOLIC BLOOD PRESSURE; DISEASE ASSOCIATION; DISEASE COURSE; FEMALE; FOLLOW UP; GRAY MATTER; HUMAN; MAJOR CLINICAL STUDY; MALE; MEAN ARTERIAL PRESSURE; NETHERLANDS; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; PROSPECTIVE STUDY; QUANTITATIVE ANALYSIS; SYSTOLIC BLOOD PRESSURE;

EID: 84882312596     PISSN: 21686149     EISSN: None     Source Type: Journal    
DOI: 10.1001/jamaneurol.2013.217     Document Type: Article

References (34)

1. de Leeuw FE, de Groot JC, OudkerkM, et al. Hypertension and cerebral white matter lesions in a prospective cohort study. Brain. 2002;125(pt 4): 765-772.
2. Debette S, Seshadri S, Beiser A, et al.Midlife vascular risk factor exposure accelerates structural brain aging and cognitive decline. Neurology. 2011;77(5):461-468.
3. Launer LJ. Epidemiology of white matter lesions. Top Magn Reson Imaging. 2004;15(6):365-367.
4. Godin O, Tzourio C, Maillard P, Mazoyer B, Dufouil C. Antihypertensive treatment and change in blood pressure are associated with the progression of white matter lesion volumes: the Three-City (3C)-DijonMagnetic Resonance Imaging Study. Circulation. 2011;123(3):266-273.
5. Law MR, Morris JK,Wald NJ. Use of blood pressure lowering drugs in the prevention of cardiovascular disease: meta-analysis of 147 randomised trials in the context of expectations from prospective epidemiological studies. BMJ. 2009;338:b1665. 19454737
6. DeCarli C, Miller BL, Swan GE, et al. Predictors of brain morphology for the men of the NHLBI twin study. Stroke. 1999;30(3):529-536.
7. Korf ES, White LR, Scheltens P, Launer LJ.Midlife blood pressure and the risk of hippocampal atrophy: the Honolulu Asia Aging Study. Hypertension. 2004;44(1):29-34.
8. Swan GE, DeCarli C, Miller BL, et al. Association of midlife blood pressure to late-life cognitive decline and brain morphology. Neurology. 1998;51(4):986-993.
9. den Heijer T, Launer LJ, Prins ND, et al. Association between blood pressure, white matter lesions, and atrophy of the medial temporal lobe. Neurology. 2005;64(2):263-267.
10. Skoog I, Andreasson LA, Landahl S, Lernfelt B. A population-based study on blood pressure and brain atrophy in 85-year-olds. Hypertension. 1998;32(3):404-409.
11. van Beek AH, Claassen JA, Rikkert MG, Jansen RW. Cerebral autoregulation: an overview of current concepts and methodology with special focus on the elderly. J Cereb Blood Flow Metab. 2008;28(6):1071-1085.
12. Kotsis V, Stabouli S, Karafillis I, Nilsson P. Early vascular aging and the role of central blood pressure. J Hypertens. 2011;29(10):1847-1853.
13. de la Torre JC. Critically attained threshold of cerebral hypoperfusion: can it cause Alzheimer's disease? Ann N Y Acad Sci. 2000;903:424-436.
14. MullerM, van der Graaf Y, Visseren FL, Vlek AL, MaliWP, Geerlings MI; SMART Study Group. Blood pressure, cerebral blood flow, and brain volume: the SMART-MR Study. J Hypertens. 2010;28(7): 1498-1505.
15. Vlek AL, Visseren FL, Kappelle LJ, et al; SMART Study Group. Blood pressure and progression of cerebral atrophy in patients with vascular disease. Am J Hypertens. 2009;22(11):1183-1189.
16. Geerlings MI, Appelman AP, Vincken KL, et al; SMART Study Group. Brain volumes and cerebrovascular lesions on MRI in patients with atherosclerotic disease: the SMART-MR Study. Atherosclerosis. 2010;210(1):130-136.
17. MullerM, van der Graaf Y, Algra A, Hendrikse J, MaliWP, Geerlings MI; SMART Study Group. Carotid atherosclerosis and progression of brain atrophy: the SMART-MR Study. Ann Neurol. 2011;70(2):237-244.
18. Anbeek P, Vincken KL, van Osch MJ, Bisschops RH, van der Grond J. Probabilistic segmentation of white matter lesions in MR imaging. Neuroimage. 2004;21(3):1037-1044.
19. Anbeek P, Vincken KL, van Bochove GS, van Osch MJ, van der Grond J. Probabilistic segmentation of brain tissue inMR imaging. Neuroimage. 2005;27(4):795-804.
20. Simons PC, Algra A, van de Laak MF, Grobbee DE, van der Graaf Y. Second Manifestations of ARTerial disease (SMART) Study: rationale and design. Eur J Epidemiol. 1999;15(9):773-781.
21. Donders AR, van der Heijden GJ, Stijnen T, Moons KG. Review: a gentle introduction to imputation ofmissing values. J Clin Epidemiol. 2006;59(10):1087-1091.
22. Rubin DB, Schenker N. Multiple imputation in health-care databases: an overview and some applications. Stat Med. 1991;10(4):585-598.
23. Enzinger C, Fazekas F, Matthews PM, et al. Risk factors for progression of brain atrophy in aging: six-year follow-up of normal subjects. Neurology. 2005;64(10):1704-1711.
24. Goldstein IB, Bartzokis G, Guthrie D, Shapiro D. Ambulatory blood pressure and the brain: a 5-year follow-up. Neurology. 2005;64(11):1846-1852.
25. Knopman DS, Penman AD, Catellier DJ, et al. Vascular risk factors and longitudinal changes on brain MRI: the ARIC Study. Neurology. 2011;76(22): 1879-1885.
26. Petrovitch H, White LR, Izmirilian G, et al. Midlife blood pressure and neuritic plaques, neurofibrillary tangles, and brain weight at death: the HAAS: Honolulu-Asia Aging Study. Neurobiol Aging. 2000;21(1):57-62.
27. Heijer Td, Skoog I, OudkerkM, et al. Association between blood pressure levels over time and brain atrophy in the elderly. Neurobiol Aging. 2003;24(2): 307-313.
28. Mitchell GF, van Buchem MA, Sigurdsson S, et al. Arterial stiffness, pressure and flow pulsatility and brain structure and function: the Age, Gene/Environment Susceptibility-Reykjavik Study. Brain. 2011;134(pt 11):3398-3407.
29. Jefferson AL. Cardiac output as a potential risk factor for abnormal brain aging. J Alzheimers Dis. 2010;20(3):813-821.
30. Iadecola C, Davisson RL. Hypertension and cerebrovascular dysfunction. Cell Metab. 2008;7(6):476-484.
31. BurkeWJ, Coronado PG, Schmitt CA, Gillespie KM, Chung HD. Blood pressure regulation in Alzheimer's disease. J Auton Nerv Syst. 1994;48(1): 65-71.
32. Kloppenborg RP, Nederkoorn PJ, Grool AM, et al; SMART Study Group. Cerebral small-vessel disease and progression of brain atrophy: the SMART-MR Study. Neurology. 2012;79(20): 2029-2036.
33. Appelman AP, Exalto LG, van der Graaf Y, Biessels GJ, MaliWP, Geerlings MI. White matter lesions and brain atrophy: more than shared risk factors? a systematic review. Cerebrovasc Dis. 2009;28(3):227-242.
34. Iadecola C, Gorelick PB. Hypertension, angiotensin, and stroke: beyond blood pressure. Stroke. 2004;35(2):348-350.